c-Fos but not v-Fos protein induces programmed cell death of v-myb-transformed monoblasts

Cellular and Molecular Life Sciences

Volumn 60, Issue 12, 2003, Pages 2736-2748

  Zahradnickova E ^a   Soucek K ^b   Sevcikova S ^a,d   Smardova J ^c   Smarda J ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AP 1; Apoptosis; Cell cycle; Differentiation; Fos; Jun; Proliferation; v Myb

Indexed keywords

PROTEIN BCL 2; PROTEIN C FOS; PROTEIN V FOS; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHICKEN; NONHUMAN; ONCOGENE; ONCOGENE V MYB; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; DOWN-REGULATION; LEUKEMIA, MONOCYTIC, ACUTE; ONCOGENE PROTEINS V-FOS; ONCOGENE PROTEINS V-MYB; PROTO-ONCOGENE PROTEINS C-FOS;

ANIMALIA; GALLUS GALLUS;

EID: 0347991767     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3263-9     Document Type: Article

References (71)

1. Karin M., Liu Z. and Zandi E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240-246
2. Liebermann D. A., Gregory B. and Hoffman B. (1998) AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int. J. Oncol. 12: 685-700
3. Shaulian E. and Karin M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131-E136
4. Sherman M. L., Stone R. M., Datta R., Bernstein S. H. and Kufe D. W. (1990) Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J. Biol. Chem. 265: 3320-3323
5. Harris P. and Ralph P. (1985) Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukoc. Biol. 37: 407-422
6. Kaminska B., Kaczmarek L., Malaguarnera L., Arcidiacono A., Messina L., Spampinato G. et al. (1992) Transcription factor activation and functional stimulation of human monocytes. Cell Biol. Int. Rep. 16: 37-45
7. Grigoriadis A. E., Wang Z. Q., Cecchini M. G., Hofstetter W., Felix R., Fleisch H. A. et al. (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448
8. Miyauchi A., Kuroki Y., Fukase M., Fujita T., Chihara K. and Shiozawa S. (1994) Persistent expression of proto-oncogene c-fos stimulates osteoclast differentiation. Biochem. Biophys. Res. Commun. 205: 1547-1555
9. Preston G. A., Lyon T. T., Yin Y., Lang J. E., Solomon G., Annab L. et al. (1996) Induction of apoptosis by c-Fos protein. Mol. Cell Biol. 16: 211-218
10. Mils V., Piette J., Barette C., Veyrune J., Tesniere A., Escot C. et al. (1997) The protooncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene 14: 1555-1561
11. Poon H. K., Tso M. O. and Lam T. T. (2000) c-Fos protein in photoreceptor cell death after photic injury in rats. Invest. Ophthalmol. Vis. Sci. 41: 2755-2758
12. Schreiber M., Baumann B., Cotten M., Angel P. and Wagner E. F. (1995) Fos is an essential component of the mammalian UV response. EMBO J. 14: 5338-5349
13. Haas S. and Kaina B. (1995) c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis 16: 985-991
14. Finkel M. P., Biskis B. O. and Jinkins P. B. (1966) Virus induction of osteosarcomas in mice. Science 151: 698-701
15. Curran T. and Verma I. M. (1984) FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product. Virology 135: 218-228
16. Nishizawa M., Goto N. and Kawai S. (1987) An avian transforming retrovirus isolated from a nephroblastoma that carries the fos gene as the oncogene. J. Virol. 61: 3733-3740
17. Piechaczyk M. and Blanchard J. M. (1994) c-fos proto-oncogene regulation and function. Crit. Rev. Oncol. Hematol. 17: 93-131
18. Gonda T. J. and Metcalf D. (1984) Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature 310: 249-251
19. Westin E. H., Gallo, R. C., Arya, S. K., Eva, A., Souza, L. M., Baluda, M. A. et al. (1982) Differential expression of the amv gene in human hematopoietic cells. Proc. Natl. Acad. Scie. USA 79: 2194-2198
20. Alitalo K., Winqvist R., Lin C. C., Chapelle A. de la, Schwab M. and Bishop J. M. (1984) Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc. Natl. Acad. Sci. USA 81: 4534-4538
21. Wallrapp C., Muller-Pillasch F., Solinas-Toldo S., Lichter P., Friess H., Buchler M. et al. (1997) Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res. 57: 3135-3139
22. Ramsay R. G., Barton A. L. and Gonda T. J. (2003) Targeting c-Myb expression in human disease. Expert Opin. Ther. Targets 7: 235-248
23. Duesberg P. H., Bister K. and Moscovici C. (1980) Genetic structure of avian myeloblastosis virus, released from transformed myeloblasts as a defective virus particle. Proc. Natl. Acad. Sci. USA 77: 5120-5124
24. Wolff L. (1996) Myb-induced transformation. Crit Rev Oncog 7: 245-260
25. Lipsick J. S. and Baluda M. A. (1986) The myb oncogene. Gene Amplif. Anal. 4: 73-98
26. Moscovici C., Gazzolo L. and Moscovici M. G. (1975) Focus assay and defectiveness of avian myeloblastosis virus. Virology 68: 173-181
27. Sevcikova S., Soucek K., Kubala L., Bryja V. and Smarda J. (2002) Differential effects of v-Jun and c-Jun proteins on v-myb-transformed monoblasts. Cell Mol. Life Sci. 59: 1690-1705
28. Curran T., Peters G., Van Beveren C., Teich N. M. and Verma I. M. (1982) FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J. Virol. 44: 674-682
29. Hughes S. H., Greenhouse J. J., Petropoulos C. J. and Sutrave P. (1987) Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61: 3004-3012
30. Ibanez C. E. and Lipsick J. S. (1988) Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation. J. Virol. 62: 1981-1988
31. Smarda J. and Lipsick J. S. (1993) Dicistronic selection for nuclear proteins in living animal cells. Gene 137: 145-149
32. Molders H., Jenuwein T., Adamkiewicz J. and Muller R. (1987) Isolation and structural analysis of a biologically active chicken c-fos cDNA: identification of evolutionarily conserved domains in Fos protein. Oncogene 1: 377-385
33. Smarda J. and Lipsick J. S. (1994) c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts. Oncogene 9: 237-245
34. Waseem N. H. and Lane D. P. (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conservation and the detection of a nucleolar form. J. Cell Sci. 96: 121-129
35. Vindelov L. L. (1977) Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions: a new method for rapid isolation and staining of nuclei. Virchows Arch. B Cell Pathol. 24: 227-242
36. Wrana J. L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M. et al. (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014
37. Smarda J., Sugarman J., Glass C. and Lipsick J. (1995) Retinoic acid receptor alpha suppresses transformation by v-Myb. Mol. Cell Biol. 15: 2474-2481
38. Engelke U., Smarda J. and Lipsick J. S. (1995) By-pass of TPA-induced differentiation and cell cycle arrest by the c-Myb DNA-binding domain. Oncogene 11: 735-741
39. Hsiang Y. H., Hertzberg R., Hecht S. and Liu L. F. (1985) Camptothecin induces protein-1 linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260: 14873-14878
40. Desagher S. and Martinou J. C. (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10: 369-377
41. Liu J. L., Klein P. A., Moscovici M. G. and Moscovici C. (1992) Monoclonal antibodies recognizing normal and retrovirus-transformed chicken hematopoietic cells. Virology 189: 583-591
42. McNagny K. M., Lim F., Grieser S. and Graf T. (1992) Cell surface proteins of chicken hematopoietic progenitors, thrombocytes and eosinophils detected by novel monoclonal antibodies. Leukemia 6: 975-984
43. Foletta V. C., Segal D. H. and Cohen D. R. (1998) Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukoc. Biol. 63: 139-152
44. Jochum W., Passegue E. and Wagner E. F. (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401-2412
45. Kovacs K. J. (1998) c-Fos as a transcription factor: a stressful (re) view from a functional map. Neurochem Int 33: 287-297
46. Shaulian E. and Karin M. (2001) AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400
47. Jacob S. T., Ghoshal K. and Sheridan J. F. (1999) Induction of metallothionein by stress and its molecular mechanisms. Gene Expr. 7: 301-310
48. Li J., King I. and Sartorelli A. C. (1994) Differentiation of WEHI-3B D+ myelomonocytic leukemia cells induced by ectopic expression of the protooncogene c-jun. Cell Growth Differ 5: 743-751
49. Karin M., Haslinger A., Heguy A., Dietlin T. and Cooke T. (1987) Metal-responsive elements act as positive modulators of human metallothionein-IIA enhancer activity. Mol. Cell Biol. 7: 606-613
50. Balsalobre A. and Jolicoeur P. (1995) Fos proteins can act as negative regulators of cell growth independently of the fos transforming pathway. Oncogene 11: 455-465
51. Garrido C., Plaza S., Gospodarowicz D. and Saule S. (1993) Fos expression induces growth arrest in tumorigenic neuroretina cells. Oncogene 8: 2713-2719
52. Kerppola T. K. and Curran T. (1991) Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity. Cell 66: 317-326
53. Ramirez-Carrozzi V. and Kerppola T. (2003) Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1. Mol. Cell Biol. 23: 1737-1749
54. McBride K. and Nemer M. (1998) The C-terminal domain of c-Fos is required for activation of an AP-1 site specific for Jun-Fos heterodimers. Mol. Cell Biol. 18: 5073-5081
55. Lane T., Ibanez C., Garcia A., Graf T. and Lipsick J. (1990) Transformation by v-myb correlates with trans-activation of gene expression. Mol. Cell Biol. 10: 2591-2598
56. Wolff L., Schmidt M., Koller R., Haviernik P., Watson R., Bies J. et al. (2001) Three genes with different functions in transformation are regulated by c-Myb in myeloid cells. Blood Cells Mol. Dis. 27: 483-488
57. Frampton J., Ramqvist T. and Graf T. (1996) v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev. 10: 2720-2731
58. Inada K., Okada S., Phuchareon J., Hatano M., Sugimoto T., Moriya H. et al. (1998) c-Fos induces apoptosis in germinal center B cells. J. Immunol. 161: 3853-3861
59. Lang D., Hubrich A., Dohle F., Terstesse M., Saleh H., Schmidt M. et al. (2000) Differential expression of heat shock protein 70 (hsp70) in human monocytes rendered apoptotic by IL-4 or serum deprivation. J. Leukoc. Biol. 68: 729-736
60. Mampuru L. J., Chen S. J., Kalenik J. L., Bradley M. E. and Lee T. C. (1996) Analysis of events associated with serum deprivation-induced apoptosis in C3H/Sol8 muscle satellite cells. Exp. Cell Res. 226: 372-380
61. Colotta F., Polentarutti N., Sironi M. and Mantovani A. (1992) Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 267: 18278-18283
62. Preston G. A., Srinivasan D. and Barrett J. C. (2000) Apoptotic response to growth factor deprivation involves cooperative interactions between c-Fos and p300. Cell Death Differ 7: 215-226
63. Curran T., Miller A. D., Zokas L. and Verma I. M. (1984) Viral and cellular Fos proteins: a comparative analysis. Cell 36: 259-268
64. Lucibello F. C., Lowag C., Neuberg M. and Muller R. (1989) trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation. Cell 59: 999-1007
65. Ofir R., Dwarki V. J., Rashid D. and Verma I. M. (1990) Phosphorylation of the C-terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature 348: 80-82
66. Chen R. H., Juo P. C., Curran T. and Blenis J. (1996) Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12: 1493-1502
67. Chen R. H., Abate C. and Blenis J. (1993) Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 90: 10952-10956
68. Gius D., Cao X. M., Rauscher F. J. 3rd, Cohen D. R., Curran T. and Sukhatme V. P. (1990) Transcriptional activation and repression by Fos are independent functions: the C-terminus represses immediate-early gene expression via CArG elements. Mol. Cell Biol. 10: 4243-4255
69. Barber J. R. and Verma I. M. (1987) Modification of Fos proteins: phosphorylation of c-Fos, but not v-Fos, is stimulated by 12-tetradecanoyl- phorbol-13-acetate and serum. Mol. Cell Biol. 7: 2201-2211
70. Dini P. W. and Lipsick J. S. (1993) Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo. Mol. Cell Biol. 13: 7334-7348
71. Zemanová K. and Smarda J. (1998) Oncoprotein v-Myb and retinoic acid receptor are mutual antagonists. Blood. Cell Mol. Dis. 15: 239-250